Cortisol and antidepressant effects of yoga

Indian Journal of Psychiatry

Volumn 55, Issue 7, 2013, Pages

  Thirthalli, J ^a   Naveen, G H ^a   Rao, M G ^a   Varambally, S ^a   Christopher, R ^a   Gangadhar, B N ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Cortisol; depression; hypercortisolemia; stress; yoga

Indexed keywords

ESCITALOPRAM; FLUOXETINE; HYDROCORTISONE; MIRTAZAPINE; SERTRALINE;

ADULT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HAMILTON SCALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; YOGA;

EID: 84883385824     PISSN: 00195545     EISSN: 19983794     Source Type: Journal    
DOI: 10.4103/0019-5545.116315     Document Type: Article

References (23)

1. Gillespie CF, Nemeroff CB. Hypercortisolemia and depression. Psychosom Med 2005;67 Suppl 1:S26-8.
2. Christensen MV, Kessing LV. The hypothalamo-pituitary-adrenal axis in major affective disorder: A review. Nord J Psychiatry 2001;55:359-63.
3. Miller GE, Rohleder N, Stetler C, Kirschbaum C. Clinical depression and regulation of the inflammatory response during acute stress. Psychosom Med 2005;67:679-87.
4. Raison CL, Miller AH. When not enough is too much: The role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 2003;160:1554-65.
5. Janakiramaiah N, Gangadhar BN, Naga Venkatesha Murthy PJ, Harish MG, Subbakrishna DK, Vedamurthachar A. Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: A randomized comparison with electroconvulsive therapy (ECT) and imipramine. J Affect Disord 2000;57:255-9.
6. Vedamurthachar A, Janakiramaiah N, Hegde JM, Shetty TK, Subbakrishna DK, Sureshbabu SV, et al. Antidepressant efficacy and hormonal effects of Sudarshana Kriya Yoga (SKY) in alcohol dependent individuals. J Affect Disord 2006;94:249-53.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (Text Revision). Washington, DC: American Psychiatric Association; 2000.
8. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (MINI.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59 Suppl 20:22-33.
9. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
10. Schüle C, Baghai TC, Eser D, Zwanzger P, Jordan M, Buechs R, et al. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients. Psychopharmacology (Berl) 2006;186:601-11.
11. Hinkelmann K, Moritz S, Botzenhardt J, Muhtz C, Wiedemann K, Kellner M, et al. Changes in cortisol secretion during antidepressive treatment and cognitive improvement in patients with major depression: A longitudinal study. Psychoneuroendocrinology 2012;37:685-92.
12. Schüle C, Baghai T, Schmidbauer S, Bidlingmaier M, Strasburger CJ, Laakmann G. Reboxetine acutely stimulates cortisol, ACTH, growth hormone and prolactin secretion in healthy male subjects. Psychoneuroendocrinology 2004;29:185-200.
13. Smith MA, Makino S, Kvetnansky R, Post RM. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995;15:1768-77.
14. Schaaf MJ, de Jong J, de Kloet ER, Vreugdenhil E. Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Res 1998;813:112-20.
15. Bravo JA, Díaz-Veliz G, Mora S, Ulloa JL, Berthoud VM, Morales P, et al. Desipramine prevents stress-induced changes in depressive-like behavior and hippocampal markers of neuroprotection. Behav Pharmacol 2009;20:273-85.
16. Lupien SJ, de Leon M, de Santi S, Convit A, Tarshish C, Nair NP, et al. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1998;1:69-73.
17. Knoops AJ, Gerritsen L, van der Graaf Y, Mali WP, Geerlings MI. Basal hypothalamic pituitary adrenal axis activity and hippocampal volumes: The SMART-Medea study. Biol Psychiatry 2010;67:1191-8.
18. Gold SM, Kern KC, O'Connor MF, Montag MJ, Kim A, Yoo YS, et al. Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms. Biol Psychiatry 2010;68:553-9.
19. Mohandas E. Neurobiology of spirituality. Mens Sana Monogr 2008;6:63-80.
20. Renaud LP. CNS pathways mediating cardiovascular regulation of vasopressin. Clin Exp Pharmacol Physiol 1996;23:157-60.
21. Pietrowsky R, Braun D, Fehm HL, Pauschinger P, Born J. Vasopressin and oxytocin do not influence early sensory processing but affect mood and activation in man. Peptides 1991;12:1385-91.
22. Yadid G, Zangen A, Herzberg U, Nakash R, Sagen J. Alterations in endogenous brain beta-endorphin release by adrenal medullary transplants in the spinal cord. Neuropsychopharmacology 2000;23:709-16.
23. Janal MN, Colt EW, Clark WC, Glusman M. Pain sensitivity, mood and plasma endocrine levels in man following long-distance running: Effects of naloxone. Pain 1984;19:13-25.